Cryoport Inc (CYRX) financials

NASDAQ · Health Care

$17.29 -5.47% Close Oct 30, 2026 Live

Cryoport revenue and earnings by year

Cryoport's revenue was $176 million in the fiscal year to December 31, 2025, up 12.4% from the year before. Net income was $78.3 million, 44.4% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 41.6% a year on average.

RevenueNet income
-$200M$0$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue176157169237223793420128
Revenue growth12.4%-7.1%-28.9%6.6%182.9%131.9%72.9%64.2%55.7%—
Gross profit8370751049736171063
Gross margin47.1%44.4%44.7%43.8%43.4%46.2%51.1%52.2%49.9%40.4%
Operating income-37-122-101-32-18-30-18-9-8-9
Operating margin-20.9%-77.6%-59.6%-13.4%-8.0%-38.1%-52.1%-44.0%-66.0%-114.2%
Net income78-115-100-37-276-33-18-10-8-13
Net margin44.4%-73.2%-59.0%-15.7%-123.8%-41.5%-54.0%-48.7%-66.1%-170.8%
Diluted EPS$1.40-$2.49-$2.21-$0.93-$5.93-$1.87————
Free cash flow-27-36-45-25-17-24-7-6-5-7

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CYRX in Markets.

How Cryoport makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Life Sciences Services$28.7M57.1%
Life Sciences Products$21.5M42.9%

See also: CYRX returns

No forecast, no recommendation. This page describes Cryoport Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.